Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (101-110 of 324) with videos related to

Pageof 33
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2006
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatmentCharles B Holmes, Robin Wood, Motasim Badri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B StudyRobert A Parker, Dustin J Rabideau, Paul E Sax, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2005
Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysisPaul E Sax, Runa Islam, Rochelle P Walensky, et al.
Open Forum Infectious Diseases|September 6, 2018
HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing?Anne M Neilan, Jennifer E Cohn, Jean-Francois Lemaire, et al.
BMJ Open|February 18, 2026
Effect of containment strategies for respiratory diseases on infections imported via international travel to the USA: a modelling studySatoshi Koiso, Hannah Lee, Andrea L Ciaranello, et al.
Antiviral Therapy|March 9, 2005
Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patientsApril D Kimmel, Sue J Goldie, Rochelle P Walensky, et al.
The Lancet. HIV|July 11, 2022
Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis BAmir M Mohareb, Joseph Larmarange, Arthur Y Kim, et al.
Plos Medicine|January 7, 2011
Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysisRochelle P Walensky, Robin Wood, Andrea L Ciaranello, et al.
The New England Journal of Medicine|February 11, 2005
Expanded screening for HIV in the United States--an analysis of cost-effectivenessA David Paltiel, Milton C Weinstein, April D Kimmel, et al.
The Journal of Infectious Diseases|September 27, 2003
Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infectionGeorge J Hanna, Henri U Balaguera, Kenneth A Freedberg, et al.
Pageof 33

Showing results (101-110 of 324) with videos related to

Sort By:
Pageof 33
Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2006
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatmentCharles B Holmes, Robin Wood, Motasim Badri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B StudyRobert A Parker, Dustin J Rabideau, Paul E Sax, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2005
Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysisPaul E Sax, Runa Islam, Rochelle P Walensky, et al.
Open Forum Infectious Diseases|September 6, 2018
HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing?Anne M Neilan, Jennifer E Cohn, Jean-Francois Lemaire, et al.
BMJ Open|February 18, 2026
Effect of containment strategies for respiratory diseases on infections imported via international travel to the USA: a modelling studySatoshi Koiso, Hannah Lee, Andrea L Ciaranello, et al.
Antiviral Therapy|March 9, 2005
Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patientsApril D Kimmel, Sue J Goldie, Rochelle P Walensky, et al.
The Lancet. HIV|July 11, 2022
Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis BAmir M Mohareb, Joseph Larmarange, Arthur Y Kim, et al.
Plos Medicine|January 7, 2011
Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysisRochelle P Walensky, Robin Wood, Andrea L Ciaranello, et al.
The New England Journal of Medicine|February 11, 2005
Expanded screening for HIV in the United States--an analysis of cost-effectivenessA David Paltiel, Milton C Weinstein, April D Kimmel, et al.
The Journal of Infectious Diseases|September 27, 2003
Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infectionGeorge J Hanna, Henri U Balaguera, Kenneth A Freedberg, et al.
Pageof 33